Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
Aug. 31, 2018
Nov. 30, 2017
Current Assets    
Cash and cash equivalents $ 7,039,972 $ 6,279,154
Marketable securities 949,763 439,322
Accounts receivable (net of allowance for doubtful accounts of $2,214,373 and $2,098,991, respectively) 5,512,863 5,125,591
Prepaid expenses 597,041 372,152
Inventory, net 16,170,057 314,566
Other current assets 209,202 206,136
Total current assets 30,478,898 12,736,921
Property and Equipment-net 1,540,242 882,382
Other Assets    
Intangible assets, net 1,368,231 226,418
Goodwill 2,007,976 0
Deferred tax assets 6,918,125 10,035,388
Deposits and other assets, net 28,888 28,888
Total other assets 10,631,220 10,290,694
Total assets 42,650,360 23,909,997
Current Liabilities    
Accounts payable 1,119,703 1,928,542
Accrued expenses 2,482,920 2,582,475
Current portion of note payable 3,100,000 2,000,000
Deferred revenue 8,209,890 7,428,829
Total current liabilities 14,912,513 13,939,846
Other Liabilities    
Deferred revenue, net of current portion 19,873,999 15,752,864
Contingent Consideration 4,698,255  
Note payable, net of current portion and debt issuance costs 11,589,093 5,295,183
Long-term liability - revenue sharing agreements 1,425,000 1,425,000
Total other liabilities 37,586,347 22,473,047
Total liabilities 52,498,860 36,412,893
Commitments and contingencies (Note 10)
Stockholders' Deficit    
Preferred stock
Common stock ($.01 par value, 20,000,000 authorized; 13,596,409 issued and 7,800,833 outstanding as of August 31, 2018 and 12,899,517 issued and 7,103,941 outstanding as of November 30, 2017) 135,965 128,995
Additional paid-incapital 35,360,801 31,373,048
Treasury stock, at cost (19,571,113) (19,571,113)
Accumulated other comprehensive income 446,120 40,865
Accumulated deficit (26,220,273) (24,474,691)
Total stockholders' deficit (9,848,500) (12,502,896)
Total liabilities and stockholders' deficit 42,650,360 23,909,997
Series A Junior Participating Preferred Stock [Member]    
Stockholders' Deficit    
Preferred stock
Tianhe Stem Cell Biotechnologies Inc [Member]    
Other Assets    
Investment $ 308,000